Spots Global Cancer Trial Database for TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
Official Title: A Phase Ib Clinical Trial of TQB2928 Injection Combined With Penpulimab in the Treatment of Patients With Advanced Malignant Tumors.
Study ID: NCT06297642
Conditions
Study Description
Brief Summary: This study will evaluate the safety and efficiency of TQB2928 injection combined with Penpulimab in the treatment of patients with advanced malignant tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Second People's Hospital of Hefei, Hefei, Anhui, China
Lu'an People's Hospital of Anhui Province, Lu'an, Anhui, China
Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing, China
Gansu Provincial Cancer Hospital, Lanzhou, Gansu, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
